Solstice Pharmaceuticals

Enschede, Netherlands Founded: 2020 • Age: 6 yrs
Ultrasound contrast agents are developed for diagnosing multiple diseases.
Request Access

About Solstice Pharmaceuticals

Solstice Pharmaceuticals is a company based in Enschede (Netherlands) founded in 2020.. Solstice Pharmaceuticals offers products and services including Harmono-T® and Activation Station. Solstice Pharmaceuticals operates in a competitive market with competitors including On Target Laboratories, Guerbet, Osprey Medical, RenalGuard Solutions and Cision Vision, among others.

  • Headquarter Enschede, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Solstice Pharmaceuticals B.V.
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $56.54 K (USD), Grant

    Feb 01, 2015

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Solstice Pharmaceuticals

Solstice Pharmaceuticals offers a comprehensive portfolio of products and services, including Harmono-T® and Activation Station. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enhances ultrasound images for improved diagnostic accuracy in medical procedures.

Activates contrast agents at bedside for uniform enhancement during examinations.

Funding Insights of Solstice Pharmaceuticals

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $56,535
  • First Round

    (01 Feb 2015)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2015 Amount Grant - Solstice Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Solstice Pharmaceuticals

Solstice Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Solstice Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Solstice Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Solstice Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Solstice Pharmaceuticals

Solstice Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as On Target Laboratories, Guerbet, Osprey Medical, RenalGuard Solutions and Cision Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Molecular imaging agents for cancer surgery are developed.
domain founded_year HQ Location
Contrast agents and delivery systems are developed for medical imaging.
domain founded_year HQ Location
Technology to reduce contrast dye exposure
domain founded_year HQ Location
Technologies for the cardiac and vascular markets
domain founded_year HQ Location
High contrast real-time imaging devices are developed for medical visualization.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Solstice Pharmaceuticals

Frequently Asked Questions about Solstice Pharmaceuticals

When was Solstice Pharmaceuticals founded?

Solstice Pharmaceuticals was founded in 2020.

Where is Solstice Pharmaceuticals located?

Solstice Pharmaceuticals is headquartered in Enschede, Netherlands. It is registered at Enschede, Overijssel, Netherlands.

What does Solstice Pharmaceuticals do?

Solstice Pharmaceuticals was founded in 2020 in Enschede, Netherlands, within the pharmaceuticals sector. Ultrasound contrast agents are developed by the company for diagnosing various diseases. Proprietary technology is utilized to create Harmono-T, an intravenous agent featuring lipid-coated gas microbubbles. Ultrasound images are enhanced through this product, enabling clinicians to assess organ perfusion and peripheral vasculature function. Operations focus on advancing diagnostic imaging solutions.

Who are the top competitors of Solstice Pharmaceuticals?

Solstice Pharmaceuticals's top competitors include Guerbet, On Target Laboratories and Osprey Medical.

What products or services does Solstice Pharmaceuticals offer?

Solstice Pharmaceuticals offers Harmono-T® and Activation Station.

Who are Solstice Pharmaceuticals's investors?

Solstice Pharmaceuticals has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available